Assignee
OMRIX BIOPHARMACEUTICALS LTD
IL·68 granted patents·13 pending applications·80 citations·filing 2005–2024
Top patents by PatentIndex Score
81 records- 0194US9915473B2Spray-drying apparatus and method of useOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Mar 13, 2018·17 cites·20 claims
- 0293US11007301B2Hemostatic mixture of cellulose-based short and long fibersOMRIX BIOPHARMACEUTICALS LTD·Filed 2018·Granted May 18, 2021·3 cites·15 claims
- 0392US11007300B2Hemostatic compositionOMRIX BIOPHARMACEUTICALS LTD·Filed 2018·Granted May 18, 2021·2 cites·4 claims
- 0491US10137221B2Hemostatic mixture of cellulose-based short and long fibersOMRIX BIOPHARMACEUTICALS LTD·Filed 2016·Granted Nov 27, 2018·9 cites·6 claims
- 0589US10137220B2Hemostatic compositionOMRIX BIOPHARMACEUTICALS LTD·Filed 2016·Granted Nov 27, 2018·7 cites·9 claims
- 0688US8354249B2Intravenous immunoglobulin compositionOMRIX BIOPHARMACEUTICALS LTD·Filed 2005·Granted Jan 15, 2013·13 cites·20 claims
- 0787US2024376459A1Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 0884US10159720B2Thrombin microcapsules, preparation and uses thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2016·Granted Dec 25, 2018·3 cites·18 claims
- 0981US11229688B2Stabilized thrombinOMRIX BIOPHARMACEUTICALS LTD·Filed 2018·Granted Jan 25, 2022·1 cites·6 claims
- 1080US12311015B2Stable liquid thrombin compositionsOMRIX BIOPHARMACEUTICALS LTD·Filed 2024·Granted May 27, 2025·0 cites·5 claims
- 1179US10849605B2Device and method for the application of a curable fluid composition to a portion of a bodily organOMRIX BIOPHARMACEUTICALS LTD·Filed 2013·Granted Dec 1, 2020·6 cites·8 claims
- 1279US2024285834A1Compositions Comprising Oxidized CelluloseOMRIX BIOPHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 1378US9814765B2One component fibrin glue comprising zymogensOMRIX BIOPHARMACEUTICALS LTD·Filed 2014·Granted Nov 14, 2017·3 cites·32 claims
- 1477US12351843B2Method for purifying and quantifying thrombin and its degradation polypeptidesOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted Jul 8, 2025·0 cites·4 claims
- 1577US11957798B2Wound dressing and a method for producing the sameOMRIX BIOPHARMACEUTICALS LTD·Filed 2022·Granted Apr 16, 2024·0 cites·3 claims
- 1677US10869912B2Thrombin microcapsules, preparation and uses thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2018·Granted Dec 22, 2020·1 cites·4 claims
- 1776US11426483B2Wound dressing and a method for producing the sameOMRIX BIOPHARMACEUTICALS LTD·Filed 2018·Granted Aug 30, 2022·2 cites·11 claims
- 1875US11712495B2Hemostatic mixture of cellulose-based short and long fibersOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted Aug 1, 2023·0 cites·7 claims
- 1975US10960105B2Hemostatic compositionOMRIX BIOPHARMACEUTICALS LTD·Filed 2020·Granted Mar 30, 2021·0 cites·9 claims
- 2074US11149263B2Method for purifying and quantifying thrombin and its degradation polypeptidesOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Granted Oct 19, 2021·0 cites·4 claims
- 2174US10131896B2Compounds and methods for stabilizing thrombin activityOMRIX BIOPHARMACEUTICALS LTD·Filed 2014·Granted Nov 20, 2018·2 cites·10 claims
- 2273US11993797B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted May 28, 2024·0 cites·12 claims
- 2373US11583573B2High concentrated protein compositions for preventing tissue adhesionOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Granted Feb 21, 2023·0 cites·5 claims
- 2473US10357589B2One component fibrin glue comprising a polymerization inhibitorOMRIX BIOPHARMACEUTICALS LTD·Filed 2017·Granted Jul 23, 2019·1 cites·3 claims
- 2572US2023158119A1High concentrated protein compositions for preventing tissue adhesionOMRIX BIOPHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 2670US11918629B2Low concentrated protein compositions for preventing tissue adhesionOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Granted Mar 5, 2024·0 cites·11 claims
- 2770US11911448B2Stable liquid thrombin compositionsOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Granted Feb 27, 2024·0 cites·5 claims
- 2870US11690937B2Antimicrobial compositions comprising minocycline and degradation products of oxidized celluloseOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted Jul 4, 2023·0 cites·5 claims
- 2970US9867852B2Viral inactivated biological mixtureOMRIX BIOPHARMACEUTICALS LTD·Filed 2013·Granted Jan 16, 2018·2 cites·22 claims
- 3069US12203947B2Device and process for sample preparationOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted Jan 21, 2025·0 cites·10 claims
- 3169US12082796B2Device and method for the application of a curable fluid composition to a bodily organOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted Sep 10, 2024·0 cites·11 claims
- 3269US11938165B2Stable pharmaceutical foamOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted Mar 26, 2024·0 cites·1 claims
- 3369US11654217B2Antimicrobial compositions comprising minocycline and oxidized celluloseOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Granted May 23, 2023·0 cites·8 claims
- 3469US11225652B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Granted Jan 18, 2022·0 cites·12 claims
- 3569US2022088156A1Stabilized thrombinOMRIX BIOPHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 3668US9943546B2Viral inactivated platelet extract, use and preparation thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2013·Granted Apr 17, 2018·1 cites·11 claims
- 3768US2023293866A1Powder dispensing applicatorOMRIX BIOPHARMACEUTICALS LTD·Filed 2023·Application pending·0 cites
- 3867US11008560B2Method for purifying and quantifying thrombin and its degradation polypeptidesOMRIX BIOPHARMACEUTICALS LTD·Filed 2018·Granted May 18, 2021·0 cites·10 claims
- 3966US11045588B2Antimicrobial compositions comprising minocycline and degradation products of oxidized celluloseOMRIX BIOPHARMACEUTICALS LTD·Filed 2018·Granted Jun 29, 2021·0 cites·10 claims
- 4066US11009513B2Device and process for sample preparationOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Granted May 18, 2021·0 cites·4 claims
- 4166US11000635B2Antimicrobial compositions comprising minocycline and oxidized celluloseOMRIX BIOPHARMACEUTICALS LTD·Filed 2018·Granted May 11, 2021·0 cites·7 claims
- 4265US11564671B2Device and method for the application of a curable fluid composition to a portion of a bodily organOMRIX BIOPHARMACEUTICALS LTD·Filed 2020·Granted Jan 31, 2023·0 cites·9 claims
- 4365US9212357B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2013·Granted Dec 15, 2015·0 cites·9 claims
- 4464US10479987B2Thrombin solution and methods of use thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Nov 19, 2019·0 cites·9 claims
- 4564US9657087B2Subcutaneous administration of anti-hepatitis B antibodiesOMRIX BIOPHARMACEUTICALS LTD·Filed 2014·Granted May 23, 2017·0 cites·3 claims
- 4663US11123397B2Stable pharmaceutical foamOMRIX BIOPHARMACEUTICALS LTD·Filed 2017·Granted Sep 21, 2021·0 cites·7 claims
- 4763US10538754B2Method for preparation of thrombinOMRIX BIOPHARMACEUTICALS LTD·Filed 2015·Granted Jan 21, 2020·1 cites·18 claims
- 4863US2020139021A1Compositions Comprising Oxidized CelluloseOMRIX BIOPHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 4962US2023190993A1Fibrinogen comprising formulation and uses thereofOMRIX BIOPHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 5061US2020261492A1Compositions Comprising Oxidized CelluloseOMRIX BIOPHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
Showing the top 50 of 81 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when OMRIX BIOPHARMACEUTICALS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →